Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Antineoplastic cephalomannine derivatives from Xechem with paclitaxel-like activity

Dec. 21, 1998

Techniclone's Rx for B-cell NHL qualifies for orphan designation

Dec. 18, 1998

NIH offers new patented therapy for primary brain tumors for licensing

Dec. 18, 1998

Novel orally active tumor angiogenesis inhibitors licensed by Cell Therapeutics

Dec. 18, 1998

Pivotal clinical trials begin for Epic's sustained-release LHRH analogue

Dec. 18, 1998

British Biotech discontinues marimastat monotherapy study in ovarian cancer

Dec. 17, 1998

Liposome Co. files for approval of Evacet in U.S.

Dec. 17, 1998

Orphan Medical files NDS for Busulfex Injection in Canada

Dec. 17, 1998

Merck KGaA prefers alliances to mergers; signs new deal with ImClone Systems

Dec. 16, 1998

Phase II trials of Xenova's P-gp pump inhibitor planned in U.S. and U.K.

Dec. 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...